Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Apr;53(4):431-5.
doi: 10.1136/hrt.53.4.431.

Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril

Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril

M A Creager et al. Br Heart J. 1985 Apr.

Abstract

The contribution of the renin-angiotensin system to the cardiovascular response to exercise was studied in 12 patients with congestive heart failure. The haemodynamic effects of captopril were measured at rest and during supine bicycle exercise. After captopril administration, resting systemic vascular resistance fell by 26.6% and mean blood pressure by 16.7% and cardiac index increased by 19.7%. During exercise, captopril decreased systemic vascular resistance by 25.6% and mean blood pressure by 8.2% and increased cardiac index by 24.4%. Pulmonary wedge pressure fell by 25% at rest but was not altered by captopril during exercise. Pretreatment plasma renin activity increased from 13.4(16.0) ng/ml/hr (10.3(12.3) mmol/l/hr) at rest to 20.0(27.8) ng/ml/hr (15.4(21.4) mmol/l/hr) during exercise. Pretreatment plasma noradrenaline concentration increased from 659(433) pg/ml (39(25.6) nmol/l) at rest to 2622(1486) pg/ml during exercise (155(88) nmol/l). Captopril favourably alters systemic vascular resistance and cardiac index during exercise in patients with congestive heart failure. This may reflect inhibition of the increased activity of the renin-angiotensin system during exercise in these patients and a subsequent reduction in systemic vasoconstriction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1980 Jun;65(6):1257-64 - PubMed
    1. Am Heart J. 1981 May;101(5):548-56 - PubMed
    1. Circulation. 1981 Sep;64(3):483-9 - PubMed
    1. Am J Cardiol. 1982 Apr 1;49(5):1152-6 - PubMed
    1. Am J Cardiol. 1982 Nov;50(5):967-72 - PubMed